Angiogenic Host Defense Peptide Ag-30/5C and Bradykinin B 2 receptor Antagonist Icatibant are G Protein Biased Agonists for MRGPRX2 in Mast Cells

Loading...
Thumbnail Image

Embargo Date

Related Collections

Degree type

Discipline

Subject

Animals; Bradykinin; Bradykinin B2 Receptor Antagonists; Cells
Cultured; HEK293 Cells; Humans; Mast Cells; Nerve Tissue Proteins; Peptides; Rats; Receptors
G-Protein-Coupled; Receptors
Neuropeptide
Dentistry

Funder

Grant number

License

Copyright date

Distributor

Related resources

Contributor

Abstract

AG-30/5C is an angiogenic host defense peptide that activates human mast cells (MC) via an unknown mechanism. Using short hairpin RNA–silenced human MC line LAD2 and stably transfected RBL-2H3 cells, we demonstrate that AG-30/5C induces MC degranulation via Mas-related G protein–coupled receptor X2 (MRGPRX2). Most G protein–coupled receptors signal via parallel and independent pathways mediated by G proteins and b-arrestins. AG-30/5C and compound 48/80 induced similar maximal MC degranulation via MRGPRX2, which was abolished by pertussis toxin. However, compound 48/80 induced a robust b-arrestin activation as determined by transcriptional activation following arrestin translocation (Tango), but AG-30/5C did not. Overnight culture of MC with compound 48/80 resulted in reduced cell surface MRGPRX2 expression, and this was associated with a significant decrease in subsequent MC degranulation in response to compound 48/80 or AG-30/5C. However, AG-30/5C pretreatment had no effect on cell surface MRGPRX2 expression or degranulation in response to compound 48/80 or AG-30/5C. Icatibant, a bradykinin B 2 receptor antagonist, promotes MC degranulation via MRGPRX2 and causes pseudoallergic drug reaction. Icatibant caused MC degranulation via a pertussis toxin–sensitive G protein but did not activate b-arrestin. A screen of the National Institutes of Health Clinical Collection library led to the identification of resveratrol as an inhibitor of MRGPRX2. Resveratrol inhibited compound 48/80–induced Tango and MC degranulation in response to compound 48/80, AG-30/5C, and Icatibant. This study demonstrates the novel finding that AG-30/5C and Icatibant serve as G protein–biased agonists for MRGPRX2, but compound 48/80 signals via both G protein and b-arrestin with distinct differences in receptor regulation. Copyright © 2019 by The American Association of Immunologists, Inc. All rights reserved

Advisor

Date Range for Data Collection (Start Date)

Date Range for Data Collection (End Date)

Digital Object Identifier

Series name and number

Publication date

2019-01-01

Journal title

Journal of Immunology

Volume number

Issue number

Publisher

Publisher DOI

Journal Issues

Comments

Recommended citation

Collection